First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Authors
Keywords
-
Journal
ANNALS OF INTERNAL MEDICINE
Volume 175, Issue 10, Pages 1392-1400
Publisher
American College of Physicians
Online
2022-10-04
DOI
10.7326/m21-2941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
- (2021) Rozalina G. McCoy et al. JAMA Network Open
- The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
- (2021) Lars Holger Ehlers et al. Diabetes Therapy
- The Longer-Term Benefits and Harms of Glucagon-Like Peptide-1 Receptor Agonists: a Systematic Review and Meta-Analysis
- (2021) Jason T. Alexander et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis
- (2021) Jason T. Alexander et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data
- (2020) Helen A. Dakin et al. MEDICAL DECISION MAKING
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Prediction of mortality and major cardiovascular complications in type 2 diabetes: External validation of UK Prospective Diabetes Study outcomes model version 2 in two European observational cohorts
- (2020) Eva Pagano et al. DIABETES OBESITY & METABOLISM
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Pouya Saeedi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- Compelling evidence for SGLT2 inhibitors and GLP-1 receptor agonists as first-line therapy in patients with diabetes at very high/high cardiovascular risk
- (2019) Niko Marx et al. EUROPEAN HEART JOURNAL
- Economic Costs of Diabetes in the U.S. in 2017
- (2018) DIABETES CARE
- Racial/Ethnic Disparities in Readmissions in US Hospitals: The Role of Insurance Coverage
- (2018) Jayasree Basu et al. INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Racial/Ethnic and Gender Disparities in Health Care Use and Access
- (2017) Jennifer I. Manuel HEALTH SERVICES RESEARCH
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes
- (2016) Tessa Peasgood et al. MEDICAL DECISION MAKING
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Change in Medical Spending Attributable to Diabetes: National Data From 1987 to 2011
- (2015) Xiaohui Zhuo et al. DIABETES CARE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regional Variation in Use of a New Class of Antidiabetic Medication Among Medicare Beneficiaries
- (2014) Zachary A. Marcum et al. ANNALS OF PHARMACOTHERAPY
- The Effect of Hypoglycemia on Health-Related Quality of Life: Canadian Results from a Multinational Time Trade-off Survey
- (2014) Stewart Harris et al. Canadian Journal of Diabetes
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Validation of the IHE Cohort Model of Type 2 Diabetes and the Impact of Choice of Macrovascular Risk Equations
- (2014) Adam Lundqvist et al. PLoS One
- Validation of the IMS CORE Diabetes Model
- (2014) Phil McEwan et al. VALUE IN HEALTH
- Review of Utility Values for Economic Modeling in Type 2 Diabetes
- (2014) Amélie Beaudet et al. VALUE IN HEALTH
- Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)
- (2014) Alex Ward et al. JOURNAL OF MEDICAL ECONOMICS
- UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
- (2013) A. J. Hayes et al. DIABETOLOGIA
- Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort
- (2013) Libo Tao et al. VALUE IN HEALTH
- Computer Modeling of Diabetes and Its Complications: A Report on the Fifth Mount Hood Challenge Meeting
- (2013) Andrew J. Palmer VALUE IN HEALTH
- External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
- (2010) S. van Dieren et al. DIABETOLOGIA
- Increasing Prevalence of Atrial Fibrillation and Flutter in the United States
- (2009) Gerald V. Naccarelli et al. AMERICAN JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search